Efficacy and safety of asfotase alfa in infants and young children with hypophosphatasia : a phase 2 open-label study

Hofmann, C.E., Harmatz, P., Vockley, J. et al. (8 more authors) (2019) Efficacy and safety of asfotase alfa in infants and young children with hypophosphatasia : a phase 2 open-label study. The Journal of Clinical Endocrinology & Metabolism, 104 (7). pp. 2735-2747. ISSN 0021-972X

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2019 Endocrine Society. This article has been published under the terms of the Creative Commons Attribution License (CC BY; https://creativecommons.org/licenses/by/4.0/).
Dates:
  • Accepted: 22 February 2019
  • Published (online): 27 February 2019
  • Published: 1 July 2019
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Oncology (Sheffield)
Funding Information:
FunderGrant number
Alexion Pharmaceuticals, IncN/A
National Institutes of Health (NIH)UL1 TR000004
Depositing User: Symplectic Sheffield
Date Deposited: 30 Aug 2019 13:48
Last Modified: 30 Aug 2019 13:48
Status: Published
Publisher: Oxford University Press (on behalf of the Endocrine Society)
Refereed: Yes
Identification Number: https://doi.org/10.1210/jc.2018-02335
Related URLs:

Download

Share / Export

Statistics